Lanreotide CAS 108736-35-2

Khoom Piav Qhia:

Khoom Lub Npe: Lanreotide CAS TSIS TAU: 108736-35-2

Lub ntsiab lus:

B-naphthyl-D-ala-cys-tyr-D-trp*lys-val-cys-thr am;

Somatuline;

Tshuaj& Lub Cev Muaj Zog:

Tsos: Dawb rau dawb-dawb lyophilized hmoov

Kev Ntsuas: ≥99.00%

Ceev: 1.4 ± 0.1 g/cm3

Kub Point: 1508.2 ℃ ntawm 760mmHg

Flash Point: 865. 9 ℃

Refractive Index: 1.689

Kev Cia Cia: -20 ℃

Vapor Siab: 0mmHg ntawm 25 ℃

Cov Ntaub Ntawv Kev Nyab Xeeb:

WGK Lub Tebchaws Yelemees: 3

Lanreotide (INN) yog cov tshuaj siv hauv kev tswj hwm acromegaly thiab cov tsos mob tshwm sim los ntawm cov qog nqaij hlav neuroendocrine, tshwj xeeb tshaj yog carcinoid syndrome. Nws yog qhov ua yeeb yam ntev ntawm somatostatin, zoo li octreotide. Nws cov ntu yog HD-2Nal-Cys (1) -Tyr-D-Trp-Lys-Val-Cys (1) -Thr-NH2.

Lanreotide (raws li lanreotide acetate) yog tsim los ntawm Ipsen, thiab ua lag luam nyob hauv kev lag luam lub npe Somatuline. Nws muaj nyob hauv ntau lub tebchaws, suav nrog Tebchaws Askiv, Australia thiab Canada, thiab tau pom zoo muag hauv Tebchaws Meskas los ntawm Food and Drug Administration (FDA) thaum Lub Yim Hli 30, 2007.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: lanreotide cas 108736-35-2, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: Octreotide CAS 79517-01-4
• Tom ntej: Oxytocin CAS 50-56-6